Doorenbos co-leading new NIH grant studying opioid use among kidney disease patients

Doorenbos co-leading new NIH grant studying opioid use among kidney disease patients

University of Illinois Cancer Center member Ardith Doorenbos, PhD, RN, FAAN, professor of biobehavioral science and co-leader of the UI Cancer Center’s Cancer Prevention and Control program, and Michael Fischer, MD, MSPH, professor of medicine, are serving as co-principal investigators on a new National Institutes of Health grant to investigate non-opioid pain management strategies for people with kidney disease, which affects about 15% of adults in the U.S.

With the funding, the University of Illinois at Chicago will be one of eight clinical centers studying alternative pain management solutions for adults on maintenance dialysis – a treatment that can help patients live for years, even though there is no cure for end-stage renal disease.

Read more from UIC Today.

Leave a reply

Your email address will not be published. Required fields are marked *